
Science Sharing | Herpes Animal Models to Facilitate Antiviral Drug Development
Introduction HSV-2 In April 2026, Moderna unveiled Phase 1/2 clinical data for mRNA-1608. This therapeutic vaccine encoding five HSV-2 antigens showed a trend of prolonged






